fbpx

Pediatric Cancer- Evidence-based, Non-Toxic Therapy Kills Kids Brain Cancer

Share Button

Medulloblastoma is the most common brain tumor in pediatric cancer patients, and its prognosis is worse…” Curcumin induced apoptosis…in medulloblastoma cells…

The only sentence that really bothers me about the study linked and excerpted below is the one that says that curcumin has the “potential to be developed into a therapeutic agent.” I am bothered only because curcumin IS a cancer therapy for a host of cancers.

Pediatric brain cancer is really tough to treat. Chemo and radiation just don’t work and they can result in awful side effects. Curcumin is both apoptotic and can synergies with chemo to enhance it’s efficacy while it minimizes it’s toxicity.

Image result for image of pediatric brain cancer patient

I have to cut the authors of the article some slack because they are writing about curcumin and pediatric cancer. I understand that kids and their caregivers may not know about the prevalence of curcumin as both a primary and integrative therapy for most cancers. Including my cancer called multiple myeloma. An “incurable” blood cancer…

When I was first diagnosed with MM I was told that the life expectancy of a MM patient was 3-5 years. That was back in 1994. I have learned that conventional (FDA approved) oncology is limited when it comes to many cancers such as MM and medulloblastoma.

 Life Extension Super Bio-curcumin, 400mg, Vegetarian Capsules, 60-CountI supplement with Life Extension Super Bio Curcumin because this formula of curcumin has been tested and evaluated by a third party independent lab for purity and strength.

I am both a long-term cancer survivor and cancer coach. If you would like to learn more about both conventional and evidence-based non-conventional therapies please scroll down the page, post a question or comment and I will reply to you ASAP.

Thank you,

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo

“Background– Medulloblastoma is the most common brain tumor in children, and its prognosis is worse than for many other common pediatric cancers. Survivors undergoing treatment suffer from serious therapy-related side effects. Thus, it is imperative to identify safer, effective treatments for medulloblastoma. In this study we evaluated the anti-cancer potential of curcumin in medulloblastoma by testing its ability to induce apoptosis and inhibit tumor growth in vitro and in vivo using established medulloblastoma models…

Results- Curcumin induced apoptosis and cell cycle arrest at the G2/M phase in medulloblastoma cells… In in vivo medulloblastoma xenografts, curcumin reduced tumor growth and significantly increased survival in the Smo/Smo transgenic medulloblastoma mouse model…

Conclusions-The in vitro and in vivo data suggest that curcumin has the potential to be developed as a therapeutic agent for medulloblastoma…”

 

Leave a Comment: